title: Evidence for more than one binding site in cloned D2 and D3 dopamine receptors.
authors.affiliation: SmithKline Beecham Pharmaceuticals, Harlow, Essex, U.K.
authors.forename: M C
authors.initials: MC
authors.lastname: Coldwell
authors.forename: W P
authors.initials: WP
authors.lastname: Bowen
authors.forename: F
authors.initials: F
authors.lastname: Brown
authors.forename: M J
authors.initials: MJ
authors.lastname: Browne
authors.forename: R
authors.initials: R
authors.lastname: Fears
authors.forename: M S
authors.initials: MS
authors.lastname: Hadley
authors.forename: F R
authors.initials: FR
authors.lastname: Hicks
authors.forename: C J
authors.initials: CJ
authors.lastname: Mannix
authors.forename: G J
authors.initials: GJ
authors.lastname: Riley
mesh_terms: D000818:Animals; D001665:Binding Sites; D016466:CHO Cells; D003001:Cloning, Molecular; D006224:Cricetinae; D006801:Humans; D007700:Kinetics; D051381:Rats; D011954:Receptors, Dopamine / Q000235:genetics / Q000378:metabolism*; D017448:Receptors, Dopamine D2 / Q000235:genetics / Q000378:metabolism*; D050637:Receptors, Dopamine D3
chemical_list: C493593:DRD3 protein, human; C493595:Drd3 protein, rat; D011954:Receptors, Dopamine; D017448:Receptors, Dopamine D2; D050637:Receptors, Dopamine D3